The reason for this is because tumor cells use an immune escape mechanism of tumor cells in the form of IFN-γ-responsive PD-L1 expression to suppress the T cell function [129], which eventually leads to immune tolerance and limits the anti-tumor application of OMVs. The gene discussed is IFNG; the disease is neoplasm.